Retention handling [Regulatives / Guidelines]

posted by Ohlbe – France, 2008-12-02 10:45 (6419 d 06:27 ago) – Posting: # 2859
Views: 2,995

Dear Alhas,

For an FDA submission the answer is clearly: NO. In case of an inspection the trial will be rejected, even if the retention samples are sent back to the CRO.

EMEA: the guideline does not require retention samples to be kept at the site. So no problem to send them back to the sponsor. Document what you do, how much you send back, the batch numbers, etc. I would suggest to keep photocopies or pictures of the containers for both the test product and the reference product.

Other markets: check in the respective guidelines.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
304 visitors (0 registered, 304 guests [including 12 identified bots]).
Forum time: 18:13 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5